Medicines and
Health Technologies

The main goal of the area of ​​Medicines and Health Technologies is to strengthen the Medicines Policy of the region, developing, together with different actors and organizations, strategies that ensure the access to medicines and the sustainability of health systems.


Work Topics

– Intellectual property
– Drug prices
– Technology Assessment

Ángela Acosta

Ángela Acosta

Graduated in Chemistry-Pharmacy from the National University of Colombia, she holds a Master’s Degree in Clinical and Sanitary Effectiveness from the University of Buenos Aires and holds a PhD in Pharmaceutical-epidemiology from the same institution. With 15 years’ experience, he has been a leader and advisor at the Ministry of Health and Social Protection of Colombia, at INVIMA (National Institute for Drug and Food Surveillance) and several projects for PAHO/WHO and the World Bank.



Universal Access to Essential Medicines: Recent South American Experiences and Challenges for the Region

        Health as a fundamental right and regional integration are part of the welfare goals agreed upon by all countries in South America. Although we have some achievements in access to medicines, it is a priority to seek and promote regional access scenarios that do not violate the precepts of essentiality and […]


The Mapping of Productive Capacity of Medicines and Health Supplies of the South American Region was launched

As the Executing Entity of the project, ISAGS will support GAUMU for the successful implementation of the project, which is of great relevance to the South American region in its drive to count as Universal Health Systems, recognizing health as a fundamental right of its population.


Regulation of Prices of Medicines in South America: Results and Concrete Strategies of Colombia

In general, medicines are an important component of health spending. Data on total pharmaceutical expenditure confirms that medicines have an important share in the total health expenditure, while this proportion varies considerably between low- and high-income countries, from a 19.7% participation in high income countries to a 30.4% in low-income countries (WHO 2011). The pharmaceutical […]


The 2018 Annual Operative Plan of ISAGS is under way

Every year, ISAGS submits to its Directing Council the work proposals for the following year. It’s the so-called Annual Operative Plan (POA 2018), which gathers and systematizes the main initiatives that will be carried out by the Institute’s different areas of action. “After an excellent year of activities and a good regional positioning in 2017, […]


The Shadow of Monopolies in the Pharmaceutical Industry

How anti-competitive practices ensure exorbitant profits while limiting the ability of Health Systems to save lives In the annals of liberal economic theories, competition stands out as a fundamental aspect to the functioning of capitalism. In its perfect version, the market would be made up of multiple consumers and multiple producers (aggregate demand and aggregate […]


Judicialization of medicines: right to health or symptoms of weaknesses in our systems?

Despite posing complex challenges, the principle that health is a fundamental right has guided the work of the South American regional health integration. How can these universal health systems be sustainable? Although UNASUR Member States have achievements towards the universal access to medicines at regional level, they face a vulnerable situation at certain occasions. Particularly, […]